ANTHONY REECE: Open Payments
NPI 1124660931 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
Products named: REXULTI, GVOKE HYPOPEN, YUPELRI, FANAPT, UBRELVY, QULIPTA.
Industry payments across ID — which companies pay providers there.
